Monday, February 13, 2012

Valeant Nabs Eyetech After Dropping Bid for ISTA - Feb. 13, 2012

Having trouble viewing this email? View in Browser.
Deals & Dollars
   Monday, February 13, 2012 Advertising Information
subscriptions careernetwork news hotbeds careerfairs
Facebook  |  Linked In  |  Twitter  |  RSS  |  Subscribe

TOP SPONSOR

From concept through clinical trial, Myriad RBM has the biomarkers, the platform and the expertise to guide your biomarker strategy. With our menu of over 400 quantitative biomarkers and proven successes in CNS, Oncology, Toxicology, Inflammation, Cardiovascular diseases, Immunology, Metabolism and many other therapeutic areas, our services can give you the insight you need to realize your biomarker success story.

To share your success story or to learn more, click here: www.myriadrbm.com/biomarkerbreakthrough/clinicaspace.
HeadHtml
•   Valeant Pharmaceuticals International (VRX) Nabs Eyetech Inc. After Dropping Bid for ISTA Pharmaceuticals, Inc. (ISTA) More...
•   Bode Technology Acquires Chromosomal Laboratories, Inc. More...
•   Bristol-Myers Squibb Company (BMY) Announces Successful Completion of Cash Tender Offer for Shares of Inhibitex, Inc. (INHX) More...

More Mergers and Acquisitions News
HeadHtml
•  DaVita Clinical Research Expands in Denver Creating 50 Specialized Research Jobs More...
More Job Industry News
HeadHtml
•  Chinese Drugmaker Guizhentang Pharmaceuticals' IPO Protested Over Bear Bile More...
More IPO News
More IPO Filing News
More IPO Withdraw
More IPO Updates
HeadHtml
•   Acasti Pharma Closes $2,000,000 CDN Private Placement More...
•   BG Medicine Secures $15 Million Loan Facility From GE Capital and Comerica More...
•   Oxitec Secures £8 Million Investment to Continue Fight Against Dengue Fever More...
More Finance News
Featured Free Resource

Building Novel Applications with Pipeline Pilot to Drive Next Generation Sequencing

This case study shows how scientists are streamlining the process of analyses of DNA sequence information. Enabled by new DNA sequencing technologies, many more scientists and informaticians are interrogating larger and more complex data set.

Request Now!
HeadHtml
•   Foundation Medicine and Dana-Farber Cancer Institute Identify Novel Genomic Alterations in Lung and Colorectal Cancer More...
•   OncoPep Enters Exclusive License Agreement with Dana-Farber Cancer Institute for Novel Therapeutic Multi-Peptide Vaccine Technology for Hematologic Cancers More...
•   Medicago, Inc. Receives Fourth Milestone Payment of US$3.56 Million from the U.S. Department of Defense More...
•   CESAR and Saladax Biomedical Inc. (SBI) Collaborate on a Study of Optimized 5-FU Dosing in Colorectal Cancer Patients More...
•   Mayo Clinic Selects Complete Genomics, Inc. to Provide Outsourced Whole Genome Sequencing More...

More Alliances News

•   AmerisourceBergen Corporation (ABC) CFO DiCandilo Resigns More...
•   Leading Proteomics Company Transitions to Emerald BioSystems, Chooses Key Leadership to Address Growing Market Opportunities More...
•   Tecan Appoints Dr David Martyr New Chief Executive Officer More...
•   Acorda Therapeutics (ACOR) Names Jane Wasman as Chief, Strategic Development More...
•   AxoGen, Inc. (LECT) Names Jill Schiaparelli Senior Vice President of Business Strategy & Marketing More...

More Personnel News
Tower: Facebook
HeadHtml
•   Elite Pharmaceuticals, Inc. (ELI) to Discuss Third Quarter 2012 Results of Operations on Wednesday, February 15, 2012 More...
•   GTX Corp to Host Fourth Quarter and Full Year 2011 Financial Results Conference Call and Webcast More...
•   ImmuCell (ICCC) Announces Product Sales Growth and Other Financial Results for 2011 More...
•   Regeneron Pharmaceuticals, Inc. (REGN) Reports Fourth Quarter and Full Year 2011 Financial and Operating Results More...
•   Salix Pharmaceuticals, Ltd. (SLXP) Announces 4Q2011 and FY2011 Financial Results Conference Call and Webcast More...

More Earnings Report News
HeadHtml
•   Bayer HealthCare Pharmaceuticals (BAYA.F) Files Suit Against Watson Pharmaceuticals, Inc. (WPI) Over Birth Control Pill Patent More...
•   Mylan Inc. (MYL) Intends to Challenge Unfavorable Verdict in Patent Trial Related to Mylan's Generic Version of Sunovion's Xopenex(R) Inhalation Solution More...

More Legal News
HeadHtml
•   TPI Begins Construction of Qionglai Facility (QLF) More...
•   DaVita Inc. (DVA) Expands in Denver More...

More Construction News
 
Real Estate



R&D/Laboratory Facility For Sublease
7 Graphics Drive
Ewing, New Jersey U.S.A.

Building Size: 72,300 SF
Available Area: 18,577 RSF
Term: May 2017

More Real Estate Listings
Feature

Hot Company

Merck Frosst Canada Ltd.
MaRS Centre - Suite 250
101 College Street
Toronto, Ontario M5G 1L7 Canada

Merck Frosst Canada Ltd. is a research-driven pharmaceutical company discovering, developing, and marketing a broad range of innovative medicines to improve human health. The Company boasts a long record of innovation and its scientific discoveries have led to medicines alleviating suffering, and prolonging and enhancing the lives of Canadians and people around the world.

More Company Profiles
Events

Even though pre-registration has ended, you can still attend the CED Life Science Conference! On-site registration is available on February 15 or 16, 2012, at the Raleigh Convention Center. The Conference is held in partnership with the North Carolina Biosciences Organization and North Carolina Biotechnology Center, and features many notable speakers, including:

• Christopher Viehbacher, CEO of Sanofi;
• Deborah Dunsire, CEO and President of Millennium: The Takeda Oncology Company;
• Alex Gorsky, Vice Chairman of J&Js Executive Committee; and
• Mehmood Khan, CSO and CEO of the Global Nutrition Group of PepsiCo.

In addition to these great keynote speakers, the Conference will feature 16 emerging-growth life science companies from North Carolina. Panels of experts will discuss the many issues surrounding life science investment strategies, the future of the industry in 2012 and beyond, and reimbursement. For a detailed agenda, visit www.cednc.org/lifescience. We'll see you in Raleigh on the 15th!
 
Top Jobs
Pharm Country (Parsippany, New Jersey)

Watson Pharmaceuticals, Inc.
Manager, Marketing Research
Establishes, coordinates and directs the market research functions and strategies. Conduct research studies and market research projects as needed; makes recommendations as appropriate.

BioMidwest (Lawrence, Kansas)

Gyrasol Technologies
Vice President of Business Development
Execute the companys marketing strategy. Develop marketing materials, represent the company at international conferences. Build a portfolio of industry contacts and evaluate new business opportunities.

Biotech Bay (San Francisco, California)

Miltenyi Biotec, Inc.
Technical Sales Consultant
Meet and/or exceed company sales forecasts in designated territory through in-depth knowledge of market segments, expert technical sales knowledge across product line, and sales skills to convert customer leads to sales. Identify potential sales leads and develop sales plan for converting leads to sales using available resources (targeted marketing, science, customer care & clinical representatives, etc).

BioCapital (Gaithersburg, Maryland)

MedImmune, LLC
Senior Marketing Operations Specialist
Will support the Marketing Operations team in planning and organizing activities affecting the Sales and Marketing team. Manage and track the design, approval, proofreading, and production processes of business collateral and promotional materials.

Genetown (Cambridgeport, Massachusetts)

Vertex
Senior Business Analyst
Responsible for partnering with members of the Commercial department (Field Operations, Reporting and Analytics, Marketing, Sales, Managed Markets) and the Medical Affairs department to assist in the continued development of the Customer Relationship Management (CRM) platform.

• Get Noticed! Add your resume to the BioSpace Career Center!
• See more than 5,000 job postings in the BioSpace Career Center!
Career Fairs

CALBIO

Genetown Career Fair

Job seekers can spend a day with HR representatives and Hiring Managers from top biotech, pharma, medical device and diagnostics companies in the Northeast region.

Candidates with a 4-year degree in the life sciences and a minimum of 2-years of industry related experience are invited to attend. (Equivalent work experience may be considered in lieu of a four-year college degree. PhD and Postdoc candidates welcome.)

Exhibiting companies are recruiting for positions in areas such as: QA/QC, clinical research, engineering, manufacturing, biostatistics, clinical data management, chemistry, regulatory affairs, and research.

Job seekers may register here.

Genetown Career Fair, Cambridge, MA February 21, 2012
BioSpace Career Fair at CALBIO2012, San Francisco, CA March 7, 2012
BioMidwest Career Fair, Bridgewater, NJ March 22, 2012
Biotech Beach Career Fair, La Jolla, CA April 17, 2012
BioCapital Career Fair, Bethesda, MD April 25, 2012
Pharm Country Career Fair, King Of Prussia, PA May 1, 2012
BioNC Career Fair, Durham, NC May 2, 2012
Biotech Bay Career Fair, Burlingame, CA May 29, 2012

More information about BioSpace's Career Fairs

BioSpace White Paper
Biotech Career Fairs For Job Seekers 101: Control Your Experience
By June Salvati, BioSpace Director of Events and Corporate Services
Contact Us

Post Your: News | Jobs | Company Profile | Event | Advertising / Sponsorship

BioSpace, Inc.
6465 South Greenwood Plaza, Suite 400
Centennial, Colorado 80111 U.S.A.
Phone: 877-277-7585
Fax: 800-595-2929
BioSpace, Inc.
90 New Montgomery Street, Suite 414
San Francisco, California 94105 U.S.A.
Phone: 877-277-7585
Fax: 415-576-9217

Send questions and comments to the BioSpace News Beat Team.

Editor & Publisher: Rosemary Do
Editorial & Production Staff: Lana Ho, Maysa Darwish, Tammy Liu, Michelle Wong

BioSpace.com - Life. Science. Community.
Legal Notice

• BioSpace is a registered trademark of BioSpace, Inc.
• Please distribute this e-cast freely.
• Credit any excerpts as follows:
Copyright 2012 BioSpace http://www.biospace.com
• While BioSpace and its agents used their best efforts in collecting and preparing the information published herein, we do not assume, and hereby disclaim, any liability for any loss or damage caused by errors or omissions, whether such errors or omissions resulted from negligence, accident or other causes.
Subscribe/Unsubscribe

If someone forwarded this news to you and you'd like to receive your own copy FREE of charge, simply Subscribe here.

Safely unsubscribe from Biospace.com e-mail at any time by managing your account here.
 


No comments: